Growth Prospects of the Clinical Immunoassay Analyzer Market in the U.SOctober 24th, 2016
QuikScreen Urine Drug Test Cups - An Ideal Option to Meet Point-of-Care Testing NeedsOctober 21st, 2016
Medica 2016 – World Forum for Medicine
Dusseldorf, GermanyBooth No: 3D29-13
AACC Annual Meeting and Clinical Lab Expo - August 1 - August 4, 2016
Philadelphia, PA USABooth No: 1845
Thanks to Block Scientific, I was able to procure the re-certified Bayer DCA 2000+ without hassles and get the lab back in operation. The
device works perfectly and I look forward to doing more business with Block Scientific.
--- Mathew Anderson, New Jersey
The JE IgG test for exposure to Japanese Encephalitis Virus (JEV) is an ELISA assay system for the detection of antibodies in human serum to JEV derived recombinant antigen (JERA) (1-4).
This test is to aid in the diagnosis of human exposure to the Japanese Encephalitis Virus (JEV). It is not intended to screen blood or blood components. It is for professional in vitro use only. In the United States this kit is intended for Research Use Only.
Exposure to JEV causes a disease with a number of symptoms including encephalitis (5-8).
The JE IgG assay employs a recombinant antigen called JERA, which can be used as a rapid serological marker for JEV infection. The JERA protein is a recombinant antigen, which consists of a stretch of peptides from different parts of the JEV antigens.